ID

44549

Descripción

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02191878

Link

https://clinicaltrials.gov/show/NCT02191878

Palabras clave

Versiones (2)
  1. 23/2/20 23/2/20 -
  2. 27/9/21 27/9/21 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatocellular Carcinoma NCT02191878

Inglés

Eligibility Hepatocellular Carcinoma NCT02191878

1 formularios  
Criteria
Descripción

Criteria

child-pugh class of a
Descripción

Child-Pugh Classification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4050412
eastern cooperative oncology group (ecog) performance status of 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
alanine aminotransferase (alt) and aspartate aminotransferase (ast) ≤5.0 × uln
Descripción

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
total bilirubin ≤3.0 mg/dl
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
platelets ≥75,000 /ml
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
international normalized ratio (inr) ≤1.7
Descripción

International Normalized Ratio

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525032
subjects must meet the protocol-defined criteria for both hepatitis b virus (hbv) and hepatitis c virus (hcv) status
Descripción

Study Protocol Criteria Fulfill | Hepatitis B Status | Hepatitis C Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0243161
UMLS CUI [1,3]
C1550543
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C0449438
UMLS CUI [3,1]
C0019196
UMLS CUI [3,2]
C0449438
key exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
history of significant cardiovascular disease will be excluded
Descripción

Cardiovascular Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
history of liver transplant.
Descripción

Transplantation of liver

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023911
diagnosis of fibrolamellar hcc or tumors of mixed histology.
Descripción

Fibrolamellar Hepatocellular Carcinoma | Neoplasms Histology Mixed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0334287
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C4048239
UMLS CUI [2,3]
C0205430
subjects known to be positive for human immunodeficiency virus (hiv) infection.
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
known central nervous system (cns) or brain metastases.
Descripción

CNS metastases | Metastatic malignant neoplasm to brain

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2]
C0220650
poorly controlled ascites and/or requirement for therapeutic paracentesis more frequently than once every 3 months.
Descripción

Ascites Poorly controlled | Requirement Paracentesis Frequency

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003962
UMLS CUI [1,2]
C3853134
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0034115
UMLS CUI [2,3]
C0439603
symptomatic encephalopathy within 3 months prior to the first dose of tkm-080301 and/or requirement for medication for encephalopathy.
Descripción

Encephalopathy Symptomatic | Requirement Pharmaceutical Preparations Encephalopathy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085584
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0085584
esophageal variceal bleeding within 2 weeks prior to the first dose of tkm-080301.
Descripción

Bleeding esophageal varices

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0155789
asthma or chronic obstructive pulmonary disease (copd) requiring daily medication.
Descripción

Asthma | Chronic Obstructive Airway Disease | Requirement Pharmaceutical Preparations Daily

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0024117
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C0332173
prior therapy with nitrosoureas or mitomycin within 6 weeks prior to the first dose of tkm-080301.
Descripción

Prior Therapy | Nitrosoureas | Mitomycin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C0028210
UMLS CUI [3]
C0002475
prior therapy with any biologic chemotherapeutic or investigational drug within 5 half-lives or 3 weeks, whichever is longer prior to the first dose of tkm 080301.
Descripción

Prior Therapy | Biological agents | Antineoplastic Agents | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514463
UMLS CUI [2]
C0005515
UMLS CUI [3]
C0003392
UMLS CUI [4]
C0013230
Volver a la parte superior de la página

Similar models

Eligibility Hepatocellular Carcinoma NCT02191878

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Child-Pugh Classification
Item
child-pugh class of a
boolean
C4050412 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
alanine aminotransferase (alt) and aspartate aminotransferase (ast) ≤5.0 × uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Serum total bilirubin measurement
Item
total bilirubin ≤3.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
Platelet Count measurement
Item
platelets ≥75,000 /ml
boolean
C0032181 (UMLS CUI [1])
International Normalized Ratio
Item
international normalized ratio (inr) ≤1.7
boolean
C0525032 (UMLS CUI [1])
Study Protocol Criteria Fulfill | Hepatitis B Status | Hepatitis C Status
Item
subjects must meet the protocol-defined criteria for both hepatitis b virus (hbv) and hepatitis c virus (hcv) status
boolean
C2348563 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0019163 (UMLS CUI [2,1])
C0449438 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0449438 (UMLS CUI [3,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Cardiovascular Disease
Item
history of significant cardiovascular disease will be excluded
boolean
C0007222 (UMLS CUI [1])
Transplantation of liver
Item
history of liver transplant.
boolean
C0023911 (UMLS CUI [1])
Fibrolamellar Hepatocellular Carcinoma | Neoplasms Histology Mixed
Item
diagnosis of fibrolamellar hcc or tumors of mixed histology.
boolean
C0334287 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C4048239 (UMLS CUI [2,2])
C0205430 (UMLS CUI [2,3])
HIV Seropositivity
Item
subjects known to be positive for human immunodeficiency virus (hiv) infection.
boolean
C0019699 (UMLS CUI [1])
CNS metastases | Metastatic malignant neoplasm to brain
Item
known central nervous system (cns) or brain metastases.
boolean
C0686377 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
Ascites Poorly controlled | Requirement Paracentesis Frequency
Item
poorly controlled ascites and/or requirement for therapeutic paracentesis more frequently than once every 3 months.
boolean
C0003962 (UMLS CUI [1,1])
C3853134 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0034115 (UMLS CUI [2,2])
C0439603 (UMLS CUI [2,3])
Encephalopathy Symptomatic | Requirement Pharmaceutical Preparations Encephalopathy
Item
symptomatic encephalopathy within 3 months prior to the first dose of tkm-080301 and/or requirement for medication for encephalopathy.
boolean
C0085584 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0085584 (UMLS CUI [2,3])
Bleeding esophageal varices
Item
esophageal variceal bleeding within 2 weeks prior to the first dose of tkm-080301.
boolean
C0155789 (UMLS CUI [1])
Asthma | Chronic Obstructive Airway Disease | Requirement Pharmaceutical Preparations Daily
Item
asthma or chronic obstructive pulmonary disease (copd) requiring daily medication.
boolean
C0004096 (UMLS CUI [1])
C0024117 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0332173 (UMLS CUI [3,3])
Prior Therapy | Nitrosoureas | Mitomycin
Item
prior therapy with nitrosoureas or mitomycin within 6 weeks prior to the first dose of tkm-080301.
boolean
C1514463 (UMLS CUI [1])
C0028210 (UMLS CUI [2])
C0002475 (UMLS CUI [3])
Prior Therapy | Biological agents | Antineoplastic Agents | Investigational New Drugs
Item
prior therapy with any biologic chemotherapeutic or investigational drug within 5 half-lives or 3 weeks, whichever is longer prior to the first dose of tkm 080301.
boolean
C1514463 (UMLS CUI [1])
C0005515 (UMLS CUI [2])
C0003392 (UMLS CUI [3])
C0013230 (UMLS CUI [4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial